Kalobios Pharmaceuticals, Inc., a biopharmaceutical company that develops cancer treatments, has commenced a case under Chapter 11 of the Bankruptcy Code by filing a petition for relief with the U.S. Bankruptcy Court for the District of Delaware. Judge Laurie Selber Silverstein will preside over the case. No claims agent has been retained; however, additional documents are available from the Court’s website.
